Amyloid-inspired Immune Adjuvants

Amyloid-inspired Immune Adjuvants

September 28, 2017


727 E. Tyler St.
Tempe, AZ 85287


Biodesign Institute, Auditorium

Date and Time

October 11, 2017, 12:00 pm (Length: 1 hour 0 minutes)

iCal Download

Jai Rudra, Ph.D., Assistant Professor, Department of Pharmacology and Toxicology, The University of Texas Medical Branch

Rudra’s team is interested in the development of nanoscale biomaterials, such as nanofibers, nanoparticles, virus-like particles and hydrogels, for engaging the immune system to induce protective antibody and cell-mediated immune responses against diseases such as tuberculosis, melanoma and flavivirus infections (West Nile and Zika). In addition, Rudra is investigating the development of vaccines against drugs of addiction, such as cocaine. 

Biomaterials immunoengineering is a multidisciplinary field that lies at the intersection of materials science, chemistry, immunology and vaccinology. Rudra collaborates with virologists, immunologists and clinicians not only to develop synthetic vaccination platforms but also to understand how biomaterials interact with the immune system and continue to develop novel materials and creative tools to tackle multidisciplinary problems in vaccine development and immunotherapy.